Humana Inc
NYSE:HUM
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
236.29
518.26
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one HUM stock under the Base Case scenario is 446.09 USD. Compared to the current market price of 289.42 USD, Humana Inc is Undervalued by 35%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Humana Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for HUM cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Humana Inc. is a leading healthcare company based in the United States, providing a robust portfolio of health insurance products and services. Founded in 1961, Humana has evolved into a key player in the Medicaid and Medicare markets, delivering a range of options that cater to individuals, families, and employers. The company’s innovative approach to health and wellness, along with its growing focus on integrated care models, positions it uniquely to meet the needs of an aging population and an increasingly diverse healthcare landscape. With a mission centered around improving health outcomes, Humana has developed a reputation for leveraging technology and data analytics to enhance patient...
Humana Inc. is a leading healthcare company based in the United States, providing a robust portfolio of health insurance products and services. Founded in 1961, Humana has evolved into a key player in the Medicaid and Medicare markets, delivering a range of options that cater to individuals, families, and employers. The company’s innovative approach to health and wellness, along with its growing focus on integrated care models, positions it uniquely to meet the needs of an aging population and an increasingly diverse healthcare landscape. With a mission centered around improving health outcomes, Humana has developed a reputation for leveraging technology and data analytics to enhance patient care and streamline operations, which is crucial in maintaining its competitive edge in the industry.
For investors, Humana represents a compelling opportunity as the demand for healthcare services continues to rise, driven by demographic shifts and the ongoing evolution of insurance models. The company has demonstrated consistent financial performance over the years, thanks to its strategic investments and a commitment to operational efficiency. Humana's recent initiatives into value-based care, coupled with partnerships and acquisitions, showcase its forward-thinking approach and dedication to sustainability. As the healthcare sector continues to innovate, Humana is well-positioned to navigate market challenges and opportunities, making it an intriguing prospect for those looking to invest in a resilient company with a solid growth trajectory.
Humana Inc. operates primarily in the healthcare sector and is one of the largest health insurance providers in the United States. Its core business segments include:
-
Retail Segment: This segment focuses on individual health insurance products, primarily Medicare Advantage plans, which provide coverage for seniors. It also includes individual and family plans available through the Affordable Care Act (ACA) marketplace. The retail segment is crucial for attracting and retaining members as it directly influences Humana's growth and profitability.
-
Group Segment: This segment caters to employer-based health plans, offering various group health insurance products, including fully insured and self-funded plans. It serves small, medium, and large businesses, providing coverage options that include medical, dental, and vision care. The Group Segment is essential for leveraging employer strategies to manage healthcare costs and improve employee benefits.
-
Healthcare Services: Humana has expanded its operations to include healthcare services such as primary care, behavioral health, and chronic condition management. This segment involves investments in healthcare delivery systems, including partnerships with primary care providers and the development of their own healthcare facilities. The goal is to enhance patient outcomes while controlling costs.
-
Pharmacy Solutions: In efforts to optimize prescription drug benefits, Humana offers pharmacy management services to its members. This segment endeavors to ensure cost-effective access to medications while emphasizing adherence and patient care.
-
Humana's Military Segment: Humana serves the U.S. Department of Defense and the Department of Veterans Affairs, providing managed care services to military personnel, their families, and retired service members.
These core business segments collectively enable Humana to deliver a comprehensive range of healthcare services and insurance products, positioning the company as a leader in the health insurance industry while also aligning with broader healthcare trends focusing on value-based care and patient-centric services.
Humana Inc. holds several unique competitive advantages over its rivals in the healthcare and insurance sectors:
-
Integrated Health Services: Humana has developed a comprehensive model that integrates health insurance with healthcare services. This includes partnerships with healthcare providers, enabling a more coordinated approach to patient care, which can lead to better health outcomes and cost savings.
-
Focus on Medicare and Medicaid: Humana has a strong presence in the Medicare Advantage market, which allows it to leverage a growing demographic of seniors who are increasingly enrolling in these programs. Its experience and brand recognition in these segments provide a competitive edge.
-
Innovative Wellness Programs: Humana is known for its investment in wellness and preventive care programs. Initiatives like Humana's “Go365” incentivize healthy behaviors among members, which can improve overall health outcomes and reduce costs associated with chronic illnesses.
-
Data Analytics: The company utilizes advanced data analytics to understand patient needs, track outcomes, and optimize healthcare delivery. This data-driven approach allows Humana to effectively manage risk and improve efficiency in their operations.
-
Telehealth Services: Humana has expanded its telehealth offerings significantly, providing members easier access to healthcare services, particularly in the wake of the COVID-19 pandemic. This enhances customer convenience and meets increasing consumer demand for remote healthcare options.
-
Strong Customer Relationships: Humana has built strong relationships with its members by focusing on personalized care and customer service. This fosters loyalty and retention, which are critical in the highly competitive health insurance market.
-
Diverse Funding Sources: By diversifying its revenue streams across various healthcare services, products, and segments (including commercial, Medicare, and Medicaid), Humana is more resilient during market fluctuations than companies that rely heavily on a single line of business.
-
Strategic Partnerships and Acquisitions: Humana has engaged in strategic partnerships and acquisitions to enhance its capabilities and extend its market reach. Such strategies help the company to innovate and provide a broader array of services.
-
Strong Brand Reputation: Humana has developed a reputation as a trusted provider of health insurance and services. This brand value can enhance customer loyalty and help attract new members within a crowded marketplace.
By leveraging these competitive advantages, Humana Inc. positions itself as a leader in the healthcare and insurance industries, focusing on innovative solutions that cater to the evolving needs of its members.
Humana Inc., like many companies in the healthcare sector, faces a number of risks and challenges that could impact its business operations and financial performance in the near future. Here are some of the key risks and challenges:
-
Regulatory Changes: Healthcare is highly regulated, and changes in government policies, especially regarding Medicare and Medicaid, could affect Humana's business model and revenue streams. Any reforms in healthcare legislation could introduce uncertainties.
-
Market Competition: The health insurance market is competitive, with various players vying for market share. Larger companies, such as UnitedHealthcare and Anthem, as well as emerging health tech companies, pose significant threats.
-
Cost Management: Rising healthcare costs and the need to manage expenditures effectively remain a challenge. Humana must balance providing high-quality care while also controlling costs to maintain profitability.
-
Technological Advancements: The rapid pace of technological change in healthcare, including telemedicine and electronic health records, requires constant adaptation and investment. Failure to keep up could result in a loss of competitive advantage.
-
Cybersecurity Threats: As a provider of healthcare services, Humana deals with sensitive personal health information. Cybersecurity risks could lead to data breaches, resulting in financial losses and damage to reputation.
-
Demographic Trends: An aging population may increase demand for healthcare services, but it could also strain resources and lead to higher costs. Additionally, changes in demographic preferences and expectations for care could affect service delivery.
-
Economic Factors: Economic downturns can impact customers' ability to pay premiums or seek necessary healthcare services, affecting Humana's revenue. Additionally, inflation can lead to increased operational costs.
-
Integration of Acquisitions: If Humana pursues acquisitions to expand its service offerings or market presence, successfully integrating new businesses can be challenging and may lead to operational disruptions.
-
Public Health Emergencies: Events like the COVID-19 pandemic can create unforeseen challenges for healthcare providers, including increased costs, shifts in service demand, and changes in consumer behavior.
-
Customer Retention and Satisfaction: With increasing options for consumers, retaining customers and ensuring high levels of satisfaction becomes crucial. Negative experiences can lead to high turnover rates.
-
Changing Consumer Behavior: Consumers are becoming more empowered and informed about their health choices. Humana must respond to this shift by enhancing customer engagement and service personalization.
To navigate these risks and challenges, Humana will need to continuously assess its strategies, invest in technology, maintain compliance with regulations, and focus on customer-centric solutions.
Balance Sheet Decomposition
Humana Inc
Cash & Short-Term Investments | 5.1B |
Insurance Receivable | 2.1B |
PP&E | 2.7B |
Long-Term Investments | 20.2B |
Other Assets | 19.9B |
Insurance Policy Liabilities | 11.1B |
Long Term Debt | 11.9B |
Other Liabilities | 9.4B |
In the latest earnings call, Humana reported exceeding expectations, forecasting at least $16 in EPS for 2024 amidst a strong Medicare Advantage (MA) product performance, expecting 5% growth. The company prioritized strategic investments, balancing near-term earnings with future growth potential, particularly through expanded clinics and improved care management efficiencies. While aiming for margin expansion in 2025, Humana bears some risks related to market conditions and clinical ratings. They anticipate a minor headwind from dual disenrollments affecting revenues but remain optimistic about long-term profitability and revenue trajectory, with a growth outlook of 5% to 5.5% in MA for 2025.
What is Earnings Call?
Wall St
Price Targets
HUM Price Targets Summary
Humana Inc
According to Wall Street analysts, the average 1-year price target for HUM is 299.89 USD with a low forecast of 249.47 USD and a high forecast of 414.75 USD.
Dividends
Current shareholder yield for HUM is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Humana Inc. engages in the provision of health insurance services. The company is headquartered in Louisville, Kentucky and currently employs 95,500 full-time employees. The firm operates through three reportable segments: Retail, Group and Specialty, and Healthcare Services. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts. The company also includes its contract to administer the limited income newly eligible transition (LI-NET), prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and long-term support services benefits. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only products. The Healthcare Services segment includes pharmacy, provider, and home services, along with other services and capabilities to promote wellness and population health.
Contact
IPO
Employees
Officers
The intrinsic value of one HUM stock under the Base Case scenario is 446.09 USD.
Compared to the current market price of 289.42 USD, Humana Inc is Undervalued by 35%.